The post Kevin Hassett Opens Door to Fed Chair Role appeared on BitcoinEthereumNews.com. Economic advisor to the White House, Kevin Hassett, has indicated that he is willing to become the next Federal Reserve chair in the event that he is appointed by President Donald Trump. His quote is made at a time when markets anticipate Fed faster Fed rate cuts. It is also proof that the central bank will take swift measures in response to weak market conditions. Hassett Remarks Align With Market’s Interest For More Rate Cuts These comments by Kevin Hassett was made on the Fox and Friends show and confirms the increasing speculation that he has become the favorite to be Fed chair when Jerome Powell vacates the position next year. A Reuters report shows Hassett stating he would be “happy to serve,” giving the clearest signal yet that he is prepared to take the role if nominated. His remarks come as election-year pressure on monetary policy grows and as prediction markets move sharply toward a specific view of the Fed’s path in 2025. Crypto market sentiment has been shifting as well, with assets like Bitcoin reacting to renewed expectations of policy easing. A Kalshi chart tracking expectations for rate cuts shows an 87% probability of exactly three cuts this year, a new all-time high. Traders are concentrating around a clear easing scenario rather than a scattered policy outcome. The chart shows traders expecting three rate cuts in 2025. Hassett Becomes Clear Favorite in Fed Leadership Race Hassett’s emergence as the leading candidate for the Fed chair adds another layer to this optimism. A separate Kalshi market tracking the next Fed chair shows Hassett leading with 55% odds. BREAKING: Kevin Hassett is now the clear favorite for the next Fed Chair at 55% odds He’s known for:• Pushing for faster rate cuts• Alignment with Trump admin• A macro view seen… The post Kevin Hassett Opens Door to Fed Chair Role appeared on BitcoinEthereumNews.com. Economic advisor to the White House, Kevin Hassett, has indicated that he is willing to become the next Federal Reserve chair in the event that he is appointed by President Donald Trump. His quote is made at a time when markets anticipate Fed faster Fed rate cuts. It is also proof that the central bank will take swift measures in response to weak market conditions. Hassett Remarks Align With Market’s Interest For More Rate Cuts These comments by Kevin Hassett was made on the Fox and Friends show and confirms the increasing speculation that he has become the favorite to be Fed chair when Jerome Powell vacates the position next year. A Reuters report shows Hassett stating he would be “happy to serve,” giving the clearest signal yet that he is prepared to take the role if nominated. His remarks come as election-year pressure on monetary policy grows and as prediction markets move sharply toward a specific view of the Fed’s path in 2025. Crypto market sentiment has been shifting as well, with assets like Bitcoin reacting to renewed expectations of policy easing. A Kalshi chart tracking expectations for rate cuts shows an 87% probability of exactly three cuts this year, a new all-time high. Traders are concentrating around a clear easing scenario rather than a scattered policy outcome. The chart shows traders expecting three rate cuts in 2025. Hassett Becomes Clear Favorite in Fed Leadership Race Hassett’s emergence as the leading candidate for the Fed chair adds another layer to this optimism. A separate Kalshi market tracking the next Fed chair shows Hassett leading with 55% odds. BREAKING: Kevin Hassett is now the clear favorite for the next Fed Chair at 55% odds He’s known for:• Pushing for faster rate cuts• Alignment with Trump admin• A macro view seen…

Kevin Hassett Opens Door to Fed Chair Role

Economic advisor to the White House, Kevin Hassett, has indicated that he is willing to become the next Federal Reserve chair in the event that he is appointed by President Donald Trump.

His quote is made at a time when markets anticipate Fed faster Fed rate cuts. It is also proof that the central bank will take swift measures in response to weak market conditions.

Hassett Remarks Align With Market’s Interest For More Rate Cuts

These comments by Kevin Hassett was made on the Fox and Friends show and confirms the increasing speculation that he has become the favorite to be Fed chair when Jerome Powell vacates the position next year. A Reuters report shows Hassett stating he would be “happy to serve,” giving the clearest signal yet that he is prepared to take the role if nominated.

His remarks come as election-year pressure on monetary policy grows and as prediction markets move sharply toward a specific view of the Fed’s path in 2025. Crypto market sentiment has been shifting as well, with assets like Bitcoin reacting to renewed expectations of policy easing.

A Kalshi chart tracking expectations for rate cuts shows an 87% probability of exactly three cuts this year, a new all-time high. Traders are concentrating around a clear easing scenario rather than a scattered policy outcome.

The chart shows traders expecting three rate cuts in 2025.

Hassett Becomes Clear Favorite in Fed Leadership Race

Hassett’s emergence as the leading candidate for the Fed chair adds another layer to this optimism. A separate Kalshi market tracking the next Fed chair shows Hassett leading with 55% odds.

Christopher Waller follows him in second position at 22% with Kevin Warsh at 12%. The chart indicates that during the last couple of sessions, the odds for Hassett spiked. This suggests that there are a lot of investors would prefer a Fed chair that supports faster rate cuts.

The odds show that Hassett is now the “clear favorite” for the position. The post highlights his reputation for supporting faster rate cuts and his close alignment with the Trump administration.

The post also states that his macro position is considered to be bullish towards stocks and crypto. These developments put Hassett at the center of political and financial discussions.

If appointed, he would start his tenure at a time when inflation is declining. Although, other indicators of economic growth are still mixed. Based on his statements, Kevin Hassett has a popular inclination towards growth-oriented policies. This makes him a key figure in discussions regarding rate cut timing and the Fed’s easing strategy.

Source: https://coingape.com/kevin-hassett-opens-door-to-fed-chair-role/

Market Opportunity
Whiterock Logo
Whiterock Price(WHITE)
$0.0001306
$0.0001306$0.0001306
-6.71%
USD
Whiterock (WHITE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26